Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)

NCT00886886 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Mood Disorder
Substance-related Disorders
Amphetamine-related Disorders

Interventions

DRUG: MDMA
DRUG: Reboxetine, 8 mg
DRUG: Placebo

Sponsor

University Hospital, Basel, Switzerland